Solventum to buy Acera Surgical for $725M
Solventum, the 3M health-care spinoff, said Friday it agreed to acquire regenerative wound care maker Acera Surgical for more than $725 million. It is Solventum's first major deal since separating from 3M last year and signals expansion in advanced wound-care products with potential impacts on the company's Twin Cities operations.
This story is compiled from 1 source using AI-assisted curation and analysis. Original reporting is attributed below. Learn about our methodology.
📌 Key Facts
- Purchase price: $725 million+
- First major acquisition since Solventum’s 2024 spinoff from 3M
- Target: Acera Surgical, a regenerative wound care company
📰 Source Timeline (1)
Follow how coverage of this story developed over time
November 21, 2025